Jump to content

JMH03

Member
  • Posts

    1143
  • Joined

  • Last visited

Everything posted by JMH03

  1. JMH03

    IPN

    remember that the offer closes 16 August 7:00pm, and Sonic health care must have received notice and processed your acceptance by this time. Though if you get your broker to accept on your behalf there still should still be sufficient time. This is by no means advice.
  2. JMH03

    IPN

    Anyone jump on this one for a quick $300? Bought 20,000 at market for 6.8c yesterday, then call your broker (ie comsec, whoever) to accept SHL takeover bid 2/3 of your holdings at 8.5c. If at close of market the day you accept the offer, your remaining 1/3 holding is under $500 (unmarketable) SHL will give ya 8.5c for the lot. IPN closed at 6.8c today so... Cost 20,000 x 6.8c = $1360 + brok Return 13,200 (2/3) x 8.5c = $1122 remaining 6,800 x 6.8 (close today) = $462.40 therefore being an unmarketable parcel so they give ya another 6,800 x 8.5c = $578 Profit = $1122 + $578- $1360 + brok =$320 http://www.ShareScene.com/html/emoticons/wink.gif there is still time, if only all trades were that easy http://www.ShareScene.com/html/emoticons/tongue.gif
  3. JMH03

    VCR

    Just hit $1.70, not far off your re-entry Ovade http://www.ShareScene.com/html/emoticons/biggrin.gif ....come on, Jump back on! you know you want to http://www.ShareScene.com/html/emoticons/icon13.gif
  4. JMH03

    VCR

    $71mil in the till 31 December 2003. I doubt they will need a nother fund raising for some time. I know there was then the large one off for the "clean room", but even if monthly budgeted burn rate was increased to $2mil, still plenty for the time being imho
  5. JMH03

    VCR

    some more great coverage of VCR in the Weekend Australian yesterday I especially like the heading http://www.ShareScene.com/html/emoticons/biggrin.gif $10bn in heart market By Chris Moriarty July 11, 2004 IN Sydney's north-western suburbs, a great Australian success story is taking shape. A cluster of global medical companies is emerging - Cochlear and Resmed are already global brands and others are on the rise, including artificial heart company Ventracor. There are about eight million people with degenerating hearts, and 10 per cent of them have fewer than 12 months to go. The problem is that each year only 3000 hearts come up for transplants. That leaves nearly 800,000 worried people on the sidelines. The solution is mass-produced artificial hearts. Open the chest, plug them in and pump away. There are four companies worldwide in this market, and one of them is Ventracor. It's a new science. Ventracor's heart has been trialled in only six patients so far. Two of them have died, but both of unrelated causes. You have to be extremely sick before you qualify to become a human guinea pig. Dr Colin Sutton is Ventracor's chief executive. His focus now is proving the product works. "We are proving we can design, develop and produce a product that works," says Dr Sutton. "Then we will get it through the regulatory hurdles." One patient has lived for 12 months. This proves that the product basically works. Ventracor has approval to test the heart in up to 10 patients in Australia. With four to go, the outlook is promising. Ventracor's heart is unique. "We have no wearing surfaces and fewer moving parts," says Dr Sutton. It goes without saying that reliability is a critical issue for this product. The key to any technology start-up is to keep the faith of your investors. If the investors are confident your word is good, they will keep on putting their money into your research and development. "We are hitting our milestones, showing the market that we do have a product that does work," says Dr Sutton. The next step is to prove to the Europeans that it works. In a trial this year, 30 Europeans will be given these Australian hearts. If they work, Ventracor will be set to become a worldwide player in a major market. In the US, artificial hearts sell for around $100,000 each. With the number of bad hearts around, along with the ageing of the population, it is easy to see how the market could well be worth the more than $10 billion a year some experts are predicting
  6. JMH03

    VCR

    I confess to being a recent Sharesguru convert- hopefully more man than mouse! http://www.ShareScene.com/html/emoticons/cool.gif I for one would like to hear Ducati's take on this weeks action...especially seeing as the only "buy" he recommended was CISCO which is downtrending, while VCR is uptrending http://www.ShareScene.com/html/emoticons/laughingsmiley.gif I should be careful what I wish for http://www.ShareScene.com/html/emoticons/lmaosmiley.gif
  7. JMH03

    VCR

    Let the good times roll http://www.ShareScene.com/html/emoticons/tongue.gif pretty to watch today....and a long time coming http://www.ShareScene.com/html/emoticons/icon13.gif congrats to all that held the faith I think she'll have no trouble taking out $1.82 ST, next major levels of resistance MT....$2, then $2.25. looks like now all the big boys have cleared VCR from their books last FY, they are ready to play again.
  8. JMH03

    VCR

    the buyers are lining up!! lets hope we see a test of resistance at $1.60 in the ST http://www.ShareScene.com/html/emoticons/tongue.gif if it breaks....up she goes http://www.ShareScene.com/html/emoticons/blink.gif
  9. JMH03

    VCR

    - down to $1.40, you can see the sellers lining up for their last chance to crystalize their loss for the year. http://www.ShareScene.com/html/emoticons/wacko.gif Today is a good buying opportunity IMHO
  10. Ive held NCM the last couple of months, up 13% so far..... The last 8 months NCM has been tested the $13 area 6 times if not more....now it has broken to a new high of $13.78, $13 is now strong support for the next advance and with gold closing at US395 (up 6) overnight we will see NCM over $14 come monday. the market is expecting the company to announce the Tefler mine operational anytime now, along with takeover speculation http://www.ShareScene.com/html/emoticons/blink.gif
  11. JMH03

    VCR

    QUOTE Health dollars (private and public) will not fund it, so where will the projected revenue come from?? I am of the understanding US medicare has already agreed to reimbruse a substantial % of the cost of LVAD's" Where did you get your information? QUOTE so looking at clinical trial results -the risk profile and mortality this product does not appear to be within cooee of being medically acceptable a competitor's 2nd generation device passed FDA approval on a 50% mortality...sure VCR has a current mortality of 40%, though the fact the first patient was implanted nearly 12 months ago and two others are doing extremely well are suggesting to me we will see significant improvements on this rate once undertaking multi-centre international trials If you have done all your research (on competitors clinical trial results), what mortality rate do you see as adequate? The fact is it is a risky business, these people a gravley ill...and unfortunatly some will die. Though the purpose of the device (and the trials) is to improve quality and duration of life. The question is how long would those people being trialled upon have lived and with what quality of life without the LVAD? The only people able to ascertain this question is the medical investigators close to the trial who have all the information available. I think it is a fair point to raise the risk/return profile on a company such as VCR, but to right it off like you did suggest an ulteria motive http://www.ShareScene.com/html/emoticons/blink.gif
  12. If you do use the method below, ensure you pay the interest on your investment loan (ie don't let it capitalise) as the courts have just ruled this to be illegal when claming a tax deduction on interest paid http://67.15.69.120/html/emoticons/thumbdown.gif
  13. There are a number of ways to gear into the share market.....a margin loan is but one. I am 26, recently married and a new father so it has been a busy 12 months to say the least. My view is it is never too early to start gearing up. Being relatively young with a long term investment horizon takes a considerable amount of risk out of investing in equities. I have an active investment account (not geared) for which I trade medium -high risk stocks (though this is only about 15-20% of our exposure to shares) For those in the situation where they have built up equity in their home, there is a far better way to gear into equities than taking out a margin loan (which involve margin calls, higher interest rates and other conditions). We have just opened up a seperate loan account with Wizards joined to our home loan for $100K using the equity in the house. So currently costing 6.57%p.a. compared to some margin loan facilities which are charging 7-9% (and the risk of margin calls etc) so on that $100,000 loan invested in solid blue chips, Im paying $6,570p.a. (assuming interst rates stay the same). Say I earn an average of 3.5-4% ($3,500-$4000 in dividends on the portfolio). $6,570-$4000 = $2,570 this is the personal tax saving (not to mention imputation credits from franking) So basically dividends earn't + tax savings negates the cost of borrowing leaving you exposed to the capital gain/loss. With a long-term investment outlook on a market averaging 8-10%, I'll ride the short term volatility into profitability http://67.15.69.120/html/emoticons/rolleyes.gif
  14. JMH03

    PC1

    great close indeed http://67.15.69.120/html/emoticons/icon13.gif hopefully that will be the last of sub 50c http://67.15.69.120/html/emoticons/wacko.gif Glad I topped up at 48c, bring on some ANN's and watch her fly.... http://67.15.69.120/html/emoticons/biggrin.gif
  15. JMH03

    PC1

    my first post on this forum, though there seem to be a number of fimilar names.... all this talk of mid 40's seem rather rash http://www.sharescene.com/html/emoticons/rolleyes.gif , though not an improbabality. Been trading ACU since 20c, still holding a substanital parcel since 20c (took some profits at 43c & 55c) Pentrys vaccine is the obvious make or break for ACU ( in many an investors eyes.... )though when discussing ACU's US business some time ago with MD Paul hopper (re :FX Risk management) I was of the opinion US10mil over 3 years is a very conservative estimate. If this figure is closer to US15-25mil (as I am happy to assume http://www.sharescene.com/html/emoticons/king.gif) , this is a substansial revenue base to develope some very promising oncology projects. On sharesguru.....back in the 30s...I suggested taking some profits between 52-58c before the run, and now I say 48c is a good base for accumulating......... for a 3- 6 month target IMHO. Hey Di....maybe time to start looking at some frocks for that $1 party http://www.sharescene.com/html/emoticons/tongue.gif
×
×
  • Create New...